• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体内抗利什曼原虫活性的安努纳摩莎提取物。

In vivo antileishmanial activity of Annona mucosa extracts.

机构信息

Universidade Federal do Amazonas, Departamento de Produção Animal e Vegetal, Manaus, AM, Brasil.

Universidade Federal do Amazonas, Departamento de Química, Manaus, AM, Brasil.

出版信息

Rev Soc Bras Med Trop. 2020 Jan 27;53:e20190139. doi: 10.1590/0037-8682-0139-2019. eCollection 2020.

DOI:10.1590/0037-8682-0139-2019
PMID:31994657
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7083374/
Abstract

INTRODUCTION

Leishmaniasis, a disease caused by a parasite endemic to large areas of tropical and subtropical countries, is a growing public health problem.

METHODS

Male BALB/c mice were infected with Leishmania amazonensis and treated with extracts isolated from Annona mucosa.

RESULTS

Treated groups had significantly reduced footpad swelling. The group treated intraperitoneally with hexane extract showed footpad swelling similar to groups treated with Pentamidine® and Glucantime®. Groups treated with dichloromethane extract and hexane extract presented the recovering phenotype associated with reduced parasite levels.

CONCLUSIONS

Extracts of A. mucosa are promising sources of novel antileishmanial compounds.

摘要

简介

利什曼病是一种由寄生虫引起的疾病,流行于热带和亚热带国家的大片地区,是一个日益严重的公共卫生问题。

方法

雄性 BALB/c 小鼠感染了亚马逊利什曼原虫,并接受了从安诺那粘膜中分离出的提取物的治疗。

结果

治疗组的足垫肿胀明显减轻。用己烷提取物腹腔内治疗的组与用戊烷脒和葡萄糖酸锑钠治疗的组的足垫肿胀相似。用二氯甲烷提取物和己烷提取物治疗的组呈现出与寄生虫水平降低相关的恢复表型。

结论

A. mucosa 的提取物是有前途的新型抗利什曼化合物的来源。

相似文献

1
In vivo antileishmanial activity of Annona mucosa extracts.体内抗利什曼原虫活性的安努纳摩莎提取物。
Rev Soc Bras Med Trop. 2020 Jan 27;53:e20190139. doi: 10.1590/0037-8682-0139-2019. eCollection 2020.
2
Leishmanicidal potentials of extract and its fractions on in a murine model: parasite burden, gene expression, and histopathological profile.在小鼠模型中, 提取物及其馏分对 的杀利什曼原虫潜力:寄生虫负担、基因表达和组织病理学特征。
J Med Microbiol. 2021 Jun;70(6). doi: 10.1099/jmm.0.001333.
3
Efficacy of the intralesional treatment with Chenopodium ambrosioides in the murine infection by Leishmania amazonensis.土荆芥皮损内注射治疗小鼠亚马逊利什曼原虫感染的疗效。
J Ethnopharmacol. 2008 Jan 17;115(2):313-9. doi: 10.1016/j.jep.2007.10.009. Epub 2007 Oct 16.
4
Antileishmanial Activities of Medicinal Herbs and Phytochemicals In Vitro and In Vivo: An Update for the Years 2015 to 2021.抗利什曼原虫草药和植物化学物质的体外和体内抗利什曼原虫活性:2015 至 2021 年的更新。
Molecules. 2022 Nov 4;27(21):7579. doi: 10.3390/molecules27217579.
5
Effect of oral treatment with the essential oil from Chenopodium ambrosioides against cutaneous leishmaniasis in BALB/c mice, caused by Leishmania amazonensis.用土荆芥精油口服治疗由亚马逊利什曼原虫引起的BALB/c小鼠皮肤利什曼病的效果。
Forsch Komplementmed. 2009 Oct;16(5):334-8. doi: 10.1159/000237741. Epub 2009 Sep 21.
6
Effect of natural naphthoquinones in BALB/c mice infected with Leishmania amazonensis and L. venezuelensis.天然萘醌对感染亚马逊利什曼原虫和委内瑞拉利什曼原虫的BALB/c小鼠的影响。
Trop Med Parasitol. 1992 Dec;43(4):219-22.
7
In vitro activity of the hydroethanolic extract and biflavonoids isolated from Selaginella sellowii on Leishmania (Leishmania) amazonensis.从巴西卷柏中分离得到的乙醇提取物和双黄酮对亚马逊利什曼原虫(利什曼原虫属)的体外活性。
Mem Inst Oswaldo Cruz. 2014 Dec;109(8):1050-6. doi: 10.1590/0074-0276140312.
8
Evaluation of total phenolic fraction derived from extra virgin olive oil for its antileishmanial activity.评价特级初榨橄榄油中总酚类物质的抗利什曼原虫活性。
Phytomedicine. 2018 Aug 1;47:143-150. doi: 10.1016/j.phymed.2018.04.030. Epub 2018 May 10.
9
In vivo efficacy of oral and intralesional administration of 2-substituted quinolines in experimental treatment of new world cutaneous leishmaniasis caused by Leishmania amazonensis.2-取代喹啉经口服和病灶内给药对亚马逊利什曼原虫引起的新大陆皮肤利什曼病进行实验性治疗的体内疗效。
Antimicrob Agents Chemother. 1996 Nov;40(11):2447-51. doi: 10.1128/AAC.40.11.2447.
10
Effect of Bixa orellana against Leishmania amazonensis.红木对亚马逊利什曼原虫的作用。
Forsch Komplementmed. 2011;18(6):351-3. doi: 10.1159/000335280. Epub 2011 Dec 9.

本文引用的文献

1
Trypanosomatids topoisomerase re-visited. New structural findings and role in drug discovery.锥虫拓扑异构酶再探讨。新的结构发现及其在药物研发中的作用。
Int J Parasitol Drugs Drug Resist. 2014 Aug 24;4(3):326-37. doi: 10.1016/j.ijpddr.2014.07.006. eCollection 2014 Dec.
2
HPLC-DAD analysis, antileishmanial, antiproliferative, and antibacterial activities of Lacistema pubescens: an Amazonian medicinal plant.柔毛拉西斯塔木(Lacistema pubescens)的高效液相色谱-二极管阵列检测分析、抗利什曼原虫、抗增殖及抗菌活性:一种亚马逊药用植物
Biomed Res Int. 2014;2014:545038. doi: 10.1155/2014/545038. Epub 2014 Aug 7.
3
Intramuscular and topical treatment of cutaneous leishmaniasis lesions in mice infected with Leishmania amazonensis using coumarin (-) mammea A/BB.
用香豆素(-)mammea A/BB 对感染利什曼原虫的感染小鼠的皮肤利什曼病病变进行肌内和局部治疗。
Phytomedicine. 2012 Oct 15;19(13):1196-9. doi: 10.1016/j.phymed.2012.08.001. Epub 2012 Sep 4.
4
Structures, targets and recent approaches in anti-leishmanial drug discovery and development.抗利什曼原虫药物研发中的结构、靶点及近期方法
Open Med Chem J. 2011;5:31-9. doi: 10.2174/1874104501105010031. Epub 2011 Mar 9.
5
Control of the leishmaniases.利什曼病的控制
World Health Organ Tech Rep Ser. 2010(949):xii-xiii, 1-186, back cover.
6
Efficacy of components from leaves of Calophyllum brasiliense against Leishmania (Leishmania) amazonensis.巴西叶绿烷叶提取物对利什曼原虫(利什曼原虫)的疗效。
Phytomedicine. 2010 Apr;17(5):333-8. doi: 10.1016/j.phymed.2009.08.011. Epub 2009 Oct 2.
7
Current treatment and drug discovery against Leishmania spp. and Plasmodium spp.: a review.针对利什曼原虫属和疟原虫属的当前治疗方法与药物研发:综述
Curr Drug Targets. 2009 Mar;10(3):178-92. doi: 10.2174/138945009787581177.
8
Topical treatment for cutaneous leishmaniasis.皮肤利什曼病的局部治疗。
Curr Opin Investig Drugs. 2002 Apr;3(4):538-44.
9
Lignans from leaves of Rollinia mucosa.番荔枝科罗林果叶中的木脂素
Z Naturforsch C J Biosci. 2002 Jan-Feb;57(1-2):29-32. doi: 10.1515/znc-2002-1-205.